Cargando…
Monoclonal antibody treatment of symptomatic COVID-19 in pregnancy: initial report
Autores principales: | Hirshberg, Jonathan S., Cooke, Emily, Oakes, Megan C., Odibo, Anthony O., Raghuraman, Nandini, Kelly, Jeannie C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8386136/ https://www.ncbi.nlm.nih.gov/pubmed/34453934 http://dx.doi.org/10.1016/j.ajog.2021.08.025 |
Ejemplares similares
-
Offering onsite COVID-19 vaccination to high-risk obstetrical patients: initial findings
por: Hirshberg, Jonathan S., et al.
Publicado: (2021) -
COVID-19 infection and diabetes in pregnancy
por: Aibangbee, Erica, et al.
Publicado: (2022) -
Characterizing initial COVID-19 vaccine attitudes among pregnancy-capable healthcare workers
por: Perez, Marta J., et al.
Publicado: (2022) -
Coronavirus disease 2019 infection among asymptomatic and symptomatic pregnant women: two weeks of confirmed presentations to an affiliated pair of New York City hospitals
por: Hirshberg, Jonathan S., et al.
Publicado: (2020) -
SARS-CoV-2 infection during pregnancy and risk of hypertensive disorders of pregnancy and preterm birth
por: Doss, James D., et al.
Publicado: (2023)